Gestational diabetes

It’s time for a heart-to-heart about women’s cardiovascular health, unique risk factors and symptoms

Retrieved on: 
Sunday, February 11, 2024

Cardiovascular disease — also called heart disease — is a condition affecting the heart and blood vessels, and is the leading cause of death among women worldwide.

Key Points: 
  • Cardiovascular disease — also called heart disease — is a condition affecting the heart and blood vessels, and is the leading cause of death among women worldwide.
  • In fact, a women dies of heart disease every 20 minutes in Canada.
  • Although cardiovascular disease is often considered a disease of men, women are more likely to die from a heart attack when compared with men.

Women’s hearts are different

  • From the outside, women’s hearts may look the same as men’s, but there are important differences.
  • Specifically, women experience unique events over the course of their lifespan which may impact their cardiovascular health.
  • Pregnancy complications, such as hypertensive disorders of pregnancy and gestational diabetes, can also play a role in cardiovascular health.

Heart attack symptoms

  • Early heart attack symptoms are missed in up to 78 per cent of women, in part related to the fact that women may present with different symptoms than men.
  • An awareness of the differences in heart attack symptoms may lead to improved recognition and timely care for women.

Reducing heart risks

  • There are many steps that you can take to reduce your risk of heart disease.
  • Living free from commercial tobacco and vaping, reducing alcohol intake and managing stress are also key ways to reduce your risk.

Wear red and learn more

  • On Feb. 13, we invite you to celebrate Wear Red Canada to raise awareness for women’s cardiovascular health, hosted by the Canadian Women’s Heart Health Alliance and the Canadian Women’s Heart Health Centre.
  • Attend free presentations and webinars by Canadian experts, join the Wear Red Canada Movement Challenge and take part in local events.


Nabilah Gulamhusein has received funding from the Canadian Institutes of Health Research through the Canada Graduate Scholarship - Master’s. Sandi Dumanski receives funding from the Canadian Fertility and Andrology Society and the Kidney Foundation.

MemorialCare Launches New Women's Heart Center and Recruits Nissi Suppogu, M.D. as Medical Director - Creating Sub-Specialized Women's Heart Health Center in Community

Retrieved on: 
Thursday, February 1, 2024

FOUNTAIN VALLEY, Calif., Feb. 1, 2024 /PRNewswire/ -- MemorialCare, a prominent nonprofit Southern California integrated health system, has announced the launch of the Women's Heart Center at the MemorialCare Heart & Vascular Institute – a specialized center dedicated solely to expertise in education, prevention, early diagnosis, and timely management of women-specific cardiac presentations across their lifespan. The Women's Heart Center's first site will be in conjunction with Long Beach Medical Center and MemorialCare Medical Group, with future plans to expand to additional MemorialCare sites in Orange County.

Key Points: 
  • The Women's Heart Center's first site will be in conjunction with Long Beach Medical Center and MemorialCare Medical Group , with future plans to expand to additional MemorialCare sites in Orange County.
  • To lead a dynamic and distinctive program such as this, MemorialCare has recruited and appointed Nissi Suppogu, M.D.
  • as the medical director of the Women's Heart Center.
  • Dr. Suppogu is fellowship trained, meaning she has two years of additional sub-specialty training and education in women's heart health.

Annals of Family Medicine: The risk of death during or shortly after childbirth is higher for people in the US than in other developed countries.

Retrieved on: 
Thursday, January 25, 2024

PROVIDENCE, R.I., Jan. 25, 2024 /PRNewswire/ -- In a new article published in Annals of Family Medicine, "A Mixed Methods Evaluation of a Quality Improvement Model to Optimize Perinatal and Primary Care in the Community Health Setting," researchers assessed a quality improvement learning collaborative's (QILC) intervention to link high-risk prenatal patients with primary care. The aims of the study were twofold: to measure the impact of the intervention on postpartum and primary care utilization for high-risk prenatal patients and to explore the Federally Qualified Health Center (FQHC) participants' experiences of working with a QI collaborative.

Key Points: 
  • Using information from patient's health records, 19 clinics within the six participating FQHCs identified high-risk prenatal patients who delivered between January and June 2021.
  • The QI intervention implemented a patient registry and conducted direct patient outreach for six months after delivery to connect patients to primary care.
  • At the conclusion of the intervention, all six FQHCs had successfully implemented processes for coordinating their maternal and primary care.
  • Complete editorial content and interactive discussion groups for each published article can be accessed for free on the journal's website, www.AnnFamMed.org .

The American Diabetes Association Releases the Standards of Care in Diabetes--2024

Retrieved on: 
Monday, December 11, 2023

ARLINGTON, Va., Dec. 11, 2023  /PRNewswire/ -- Today, the American Diabetes Association® (ADA) released the Standards of Care in Diabetes—2024 (Standards of Care), a set of comprehensive and evidence-based guidelines for managing type 1, type 2, gestational diabetes, and prediabetes based on the latest scientific research and clinical trials. It includes strategies for diagnosing and treating diabetes in both youth and adults, methods to prevent or delay type 2 diabetes and its associated comorbidities like cardiovascular disease (CVD) and obesity, and therapeutic approaches aimed at minimizing complications and enhancing health outcomes.

Key Points: 
  • "The latest ADA guidelines present pivotal updates for health care professionals, ensuring comprehensive, evidence-based care for diabetes management.
  • "The ADA's Standards of Care ensures health care professionals, especially our primary care workforce, provide the best possible care to those living with diabetes."
  • The Standards of Care are critical to ensuring the improved treatment of diabetes, a chronic disease that requires continuous care through a well-informed and coordinated health care team.
  • Today, the Standards of Care in Diabetes—2024 is available online and is published as a supplement to the January 2024 issue of Diabetes Care® .

Type 1 Diabetes Market to Accelerate Substantially During the Study Period (2019-2032), Predicts DelveInsight | Leading Companies Developing Therapies - Eli Lilly, Vertex, Bayer, Novo Nordisk, Rise, Tolerion, BioKier, Dompé Farmaceutici

Retrieved on: 
Wednesday, November 15, 2023

LAS VEGAS, Nov. 15, 2023 /PRNewswire/ -- DelveInsight's Type 1 Diabetes Market Insights report includes a comprehensive understanding of current treatment practices, type 1 diabetes emerging drugs, market share of individual therapies, and current and forecasted market size from 2019 to 2032, segmented into 7MM [the United States, the EU-4 (Italy, Spain, France, and Germany), the United Kingdom, and Japan].

Key Points: 
  • According to the International Diabetes Federation (IDF), Type 1 diabetes may affect anybody at any age, although it impacts children and adolescents the most commonly.
  • Over 1 million children and adolescents under the age of 20 have type 1 diabetes.
  • Diabetes is medically categorized into three primary types, with Type 1 diabetes, Type 2 diabetes, and gestational diabetes being the main classifications.
  • To know more about type 1 diabetes treatment, visit @ Type 1 Diabetes Treatment Drugs

Type 1 Diabetes Market to Accelerate Substantially During the Study Period (2019-2032), Predicts DelveInsight | Leading Companies Developing Therapies - Eli Lilly, Vertex, Bayer, Novo Nordisk, Rise, Tolerion, BioKier, Dompé Farmaceutici

Retrieved on: 
Wednesday, November 15, 2023

LAS VEGAS, Nov. 15, 2023 /PRNewswire/ -- DelveInsight's Type 1 Diabetes Market Insights report includes a comprehensive understanding of current treatment practices, type 1 diabetes emerging drugs, market share of individual therapies, and current and forecasted market size from 2019 to 2032, segmented into 7MM [the United States, the EU-4 (Italy, Spain, France, and Germany), the United Kingdom, and Japan].

Key Points: 
  • According to the International Diabetes Federation (IDF), Type 1 diabetes may affect anybody at any age, although it impacts children and adolescents the most commonly.
  • Over 1 million children and adolescents under the age of 20 have type 1 diabetes.
  • Diabetes is medically categorized into three primary types, with Type 1 diabetes, Type 2 diabetes, and gestational diabetes being the main classifications.
  • To know more about type 1 diabetes treatment, visit @ Type 1 Diabetes Treatment Drugs

Food For Health partners with iCare to address hypertension, type 2 diabetes

Retrieved on: 
Tuesday, November 14, 2023

MILWAUKEE, Nov. 14, 2023 /PRNewswire/ -- Managing hypertension and type 2 diabetes is challenging under any circumstance, but increasingly so for residents of underserved communities.

Key Points: 
  • To address this challenge, Food For Health is partnering with Humana-subsidiary Independent Care Health Plan, or iCare, to provide Medically Tailored Meal programming for Medicaid members who are patients of Milwaukee Health Services Clinics.
  • Today's announcement coincides with World Diabetes Day, a global awareness campaign around the growing concerns of the escalating health threats of diabetes.
  • "Our patient-centric program is proven to reverse, manage and prevent diet-related disease including type 2 diabetes, hypertension, cardiovascular disease, and maternal health concerns, specifically gestational diabetes and preeclampsia."
  • iCare and Milwaukee Health Services' MLK Heritage Health Center identify members who meet the enrollment criteria.

Needed Raises $14M to Champion a Radically Better Nutrition Standard for Women

Retrieved on: 
Tuesday, November 7, 2023

Key Points: 
  • View the full release here: https://www.businesswire.com/news/home/20231107679237/en/
    Julie Sawaya and Ryan Woodbury, Needed co-founders and co-CEOs (Photo: Business Wire)
    Needed is known for its system of radically better, science-backed nutritional supplements for women in the perinatal stage.
  • “Nutrition is one of the most significant and most overlooked decisions made in the pregnancy journey,” said Julie Sawaya, Needed co-founder and co-CEO.
  • “However, nutrition is often relegated to an afterthought and women are left with more questions than answers about their nutritional needs.
  • Needed is setting a new, radically better standard for perinatal nutrition combining the products, education, and access to nutritional experts that all women need and deserve.”
    “Nutrition changes perinatal outcomes.

StoryMD, a First-of-its-Kind, Interactive Health Platform, Launches A Mother's Journey, an Intimate Guide to Conceiving and Nurturing a New Life

Retrieved on: 
Wednesday, November 1, 2023

NEW YORK, Nov. 1, 2023 /PRNewswire/ -- StoryMD, a first-of-its-kind, interactive health platform with one of the world's largest digital libraries of vetted, scientific medical information, has launched A Mother's Journey - An Intimate Guide to Conceiving and Nurturing a New Life. A Mother's Journey is a one-stop ecosystem that provides new and aspiring parents with a better way to understand and manage their fertility and pregnancy journeys.

Key Points: 
  • NEW YORK, Nov. 1, 2023 /PRNewswire/ -- StoryMD , a first-of-its-kind, interactive health platform with one of the world's largest digital libraries of vetted, scientific medical information, has launched A Mother's Journey - An Intimate Guide to Conceiving and Nurturing a New Life.
  • A Mother's Journey is a one-stop ecosystem that provides new and aspiring parents with a better way to understand and manage their fertility and pregnancy journeys.
  • StoryMD's A Mother's Journey - An Intimate Guide to Conceiving and Nurturing a New Life includes the following proprietary features.
  • Communities: Another key feature of StoryMD's A Mother's Journey are the supportive online communities, organized according to specific HealthJournal topics.

Government of Canada Announces Semi-finalists of the Type 2 Diabetes Prevention Challenge

Retrieved on: 
Wednesday, November 1, 2023

Through Budget 2021 funding and in partnership with Impact Canada, PHAC launched the Type 2 Diabetes Prevention Challenge in Fall 2022 to attract innovators to develop and implement community, co-designed approaches to prevent type 2 diabetes.

Key Points: 
  • Through Budget 2021 funding and in partnership with Impact Canada, PHAC launched the Type 2 Diabetes Prevention Challenge in Fall 2022 to attract innovators to develop and implement community, co-designed approaches to prevent type 2 diabetes.
  • That's why we are working with Impact Canada and other partners on the diabetes challenge to promote new, innovative ways to address the risks that lead to developing type 2 diabetes.
  • I would like to thank all participants for their hard work and offer my congratulations to the 20 semi-finalists of the Type 2 Diabetes Prevention Challenge.
  • There are three main types of diabetes: type 1, type 2, and gestational diabetes.